Upstream Bio, Inc.
UPB
$8.56
-$0.09-1.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -150.32% | -79.51% | -415.54% | -288.93% | |
| Total Depreciation and Amortization | 230.77% | 250.00% | -17.65% | -10.34% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 136.69% | 1,202.28% | 127.11% | 30.33% | |
| Change in Net Operating Assets | -287.57% | 67.28% | -76.55% | -131.73% | |
| Cash from Operations | -134.40% | -21.74% | -189.73% | -106.65% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -1,640.43% | 903.00% | -85.84% | 130.88% | |
| Cash from Investing | -1,640.43% | 899.47% | -88.50% | 130.83% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -81.00% | 104,200.00% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -100.36% | 203,594.74% | -3,382.00% | -85.52% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -4,584.41% | 1,463.48% | -289.76% | -50.17% | |